Miconazole Aerosol Powder/Liquid Clinical Trials

• Effects of Miconazole on Blood Flow
  ClinicalTrials.gov Identifier: NCT00004575 - Completed
  Healthy
  
• Study of Asthma in Patients of African Descent
  ClinicalTrials.gov Identifier: NCT00102765 - Active, not recruiting
  Asthma
  
• Effects of Garlic Supplements On Drug Metabolism
  ClinicalTrials.gov Identifier: NCT00122889 - Recruiting
  Healthy
  
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children with HIV Infection: Canada
  ClinicalTrials.gov Identifier: NCT00162188 - Recruiting
  HIV Infection
  
• Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00388882 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
  ClinicalTrials.gov Identifier: NCT00458835 - Active, not recruiting
  Allergic Rhinitis
  
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325364 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
  ClinicalTrials.gov Identifier: NCT00475371 - Active, not recruiting
  Diabetes Mellitus, Type 2; Healthy Males
  
• Study of Topiramate Administered as Liquid or Sprinkles in Infants (Aged 1-23 Months) With Refractory POS
  ClinicalTrials.gov Identifier: NCT00233012 - Active, not recruiting
  Seizures
  
• Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function
  ClinicalTrials.gov Identifier: NCT00528216 - Active, not recruiting
  Pain
  
• Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of MEDI-493, Synagis
  ClinicalTrials.gov Identifier: NCT00233064 - Active, not recruiting
  Chronic Lung Disease
  
• A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals’ HRV Liquid Vaccine in Healthy Infants.
  ClinicalTrials.gov Identifier: NCT00432380 - Active, not recruiting
  Rotavirus Gastroenteritis
  
• A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00359788 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents
  ClinicalTrials.gov Identifier: NCT00207519 - Active, not recruiting
  Overweight; Obesity
  
• A Study in Infants to Test Two Preparations (Freeze-Dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
  ClinicalTrials.gov Identifier: NCT00382772 - Active, not recruiting
  Gastroenteritis
  
• A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects with Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00116103 - Completed
  Asthma
  
• Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418AM4)
  ClinicalTrials.gov Identifier: NCT00394355 - Recruiting
  Asthma
  
• A Pilot Study of Aerosol Interferon-Gamma for Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00563212 - Recruiting
  Pulmonary Fibrosis
  
• A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD
  ClinicalTrials.gov Identifier: NCT00446667 - Recruiting
  COPD; Exacerbation
  
• Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00492141 - Recruiting
  Ewing's Sarcoma; Lung Cancer
  
• A Study of the Equivalent Effectiveness of 400 Mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)
  ClinicalTrials.gov Identifier: NCT00521599 - Recruiting
  Asthma
  
• Study Of Asthma And Genetics
  ClinicalTrials.gov Identifier: NCT00102882 - Completed
  Asthma
  
• Efficacy and Safety Study of Oral Glycopyrrolate Liquid to Manage Problem Drooling Associated With Cerebral Palsy or Other Neurologic Conditions in Children
  ClinicalTrials.gov Identifier: NCT00425087 - Active, not recruiting
  Sialorrhea; Cerebral Palsy; Neurological Condition; Mental Retardation
  
• 4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00531180 - Recruiting
  Lung Cancer
  
• Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study
  ClinicalTrials.gov Identifier: NCT00446680 - Recruiting
  Cystic Fibrosis
  
• Bronchodilatory Efficacy of a Single Dose QMF149 Via a Multiple-Dose Dry Powder Inhaler (MDDPI) in Adult Asthma Patients
  ClinicalTrials.gov Identifier: NCT00556673 - Recruiting
  Asthma
  
• A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00175877 - Active, not recruiting
  Rheumatoid Arthritis
  
• Efficacy of Tiotropium in Patients of African Descent with Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00106821 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
  Hepatitis C
  
• Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
  ClinicalTrials.gov Identifier: NCT00426920 - Not yet recruiting
  Diabetes Mellitus
  
• Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
  ClinicalTrials.gov Identifier: NCT00378677 - Recruiting
  Lung Transplantation; Bronchiolitis Obliterans
  
• Dose-Ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
  ClinicalTrials.gov Identifier: NCT00504426 - Recruiting
  Pain Due to Osteoporosis
  
• Evaluation of Liquid vs. Tablet Buprenorphine - 6
  ClinicalTrials.gov Identifier: NCT00000341 - Active, not recruiting
  Opioid-Related Disorders
  
• Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
  ClinicalTrials.gov Identifier: NCT00312091 - Recruiting
  HIV Infections
  
• High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
  ClinicalTrials.gov Identifier: NCT00247143 - Recruiting
  HIV; AIDS
  
• A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00160641 - Active, not recruiting
  Rheumatoid Arthritis
  
• Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00071201 - Active, not recruiting
  Chronic Hepatitis B
  
• Bio-Availability of a New Liquid Tumeric Extract
  ClinicalTrials.gov Identifier: NCT00542711 - Not yet recruiting
  Healthy
  
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00388505 - Recruiting
  Cystic Fibrosis
  
• Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00500539 - Recruiting
  Asthma
  
• Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
  ClinicalTrials.gov Identifier: NCT00390780 - Completed
  HIV Infections
  
• Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation
  ClinicalTrials.gov Identifier: NCT00502021 - Not yet recruiting
  Morbid Obesity; Atherosclerosis; Systemic Inflammation
  
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00162227 - Recruiting
  HIV Infection
  
• Safety Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Condition
  ClinicalTrials.gov Identifier: NCT00491894 - Recruiting
  Sialorrhea; Cerebral Palsy; Neurological Conditions; Mental Retardation
  
• A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
  ClinicalTrials.gov Identifier: NCT00281606 - Not yet recruiting
  HIV Infection
  
• Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
  ClinicalTrials.gov Identifier: NCT00144846 - Recruiting
  acute wheezing obstructive airways disease
  
• Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
  ClinicalTrials.gov Identifier: NCT00346827 - Not yet recruiting
  Parkinson's Disease
  
• Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects
  ClinicalTrials.gov Identifier: NCT00125346 - Suspended
  Cystic Fibrosis
  
• Effect of Arista Powder on Bleeding in Reductive Mammary Surgery
  ClinicalTrials.gov Identifier: NCT00227084 - Completed
  Mammaplasty
  
• Aerosol Cyclosporine for Prevention of Lung Rejection
  ClinicalTrials.gov Identifier: NCT00268515 - Completed
  Lung Diseases
  
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Sallmeterol Inhalation Aerosol.
  ClinicalTrials.gov Identifier: NCT00274560 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)
  ClinicalTrials.gov Identifier: NCT00443482 - Completed
  Asthma
  
• A Pilot Study of Aerosol Interferon-Gamma Treatment in Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00212563 - Completed
  Idiopathic Pulmonary Fibrosis
  
• Enbrel Liquid Immunogenicity Protocol
  ClinicalTrials.gov Identifier: NCT00249041 - Completed
  Rheumatoid Arthritis
  
• Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
  ClinicalTrials.gov Identifier: NCT00413387 - Completed
  Bronchial Asthma
  
• A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00455130 - Completed
  Cystic Fibrosis
  
• Recombinant Human IL-4 Receptor Used in Treatment of Asthma
  ClinicalTrials.gov Identifier: NCT00017693 - Completed
  Asthma
  
• Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00403637 - Completed
  Asthma
  
• Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)
  ClinicalTrials.gov Identifier: NCT00192387 - Completed
  Influenza
  
• Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects
  ClinicalTrials.gov Identifier: NCT00000362 - Terminated
  Pneumonia, Aspiration
  
• Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00539890 - Completed
  Diabetes Type 2
  
• To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)
  ClinicalTrials.gov Identifier: NCT00345956 - Completed
  Gastroenteritis; Rotavirus Infections
  
• Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.
  ClinicalTrials.gov Identifier: NCT00192400 - Completed
  Healthy
  
• Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway
  ClinicalTrials.gov Identifier: NCT00248755 - Completed
  Cystic Fibrosis
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)
  ClinicalTrials.gov Identifier: NCT00192231 - Completed
  Influenza
  
• Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004705 - Completed
  Cystic Fibrosis
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children
  ClinicalTrials.gov Identifier: NCT00192322 - Completed
  Influenza
  
• Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)
  ClinicalTrials.gov Identifier: NCT00099515 - Completed
  Diabetes Mellitus, Type 2
  
• Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
  ClinicalTrials.gov Identifier: NCT00192374 - Completed
  Healthy
  
• Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00465959 - Completed
  Chronic Obstructive Pulmonary Disease
  
• A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)
  ClinicalTrials.gov Identifier: NCT00240929 - Completed
  -Unhealthy Children With a History of Prematurity
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00192192 - Completed
  Influenza
  
• Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00413426 - Completed
  Healthy
  
• A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis carinii Pneumonia in Patients With AIDS Post First Episode PCP
  ClinicalTrials.gov Identifier: NCT00002053 - Completed
  Pneumonia, Pneumocystis carinii; HIV Infections
  
• An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients
  ClinicalTrials.gov Identifier: NCT00002030 - Completed
  Pneumonia, Pneumocystis carinii; HIV Infections
  
• A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP
  ClinicalTrials.gov Identifier: NCT00002055 - Completed
  Pneumonia, Pneumocystis carinii; HIV Infections
  
• Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00117182 - Completed
  Lung Diseases, Obstructive
  
• Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00396604 - Completed
  Pulmonary Disease, Chronic Obstructive; COPD; Lung Diseases, Obstructive
  
• A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients
  ClinicalTrials.gov Identifier: NCT00002054 - Completed
  Pneumonia, Pneumocystis carinii; HIV Infections
  
• Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
  ClinicalTrials.gov Identifier: NCT00063128 - Completed
  Diabetes Mellitus, Type 1
  
• A Cross-Over Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Haemodialysis Patients.
  ClinicalTrials.gov Identifier: NCT00267514 - Completed
  Chronic Kidney Disease; Hemodialysis
  
• A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections
  ClinicalTrials.gov Identifier: NCT00021567 - Completed
  Mycobacterium avium-intracellulare Infection
  
• A Randomized, Double-Blind Trial To Assess The Safety And Relative Efficacy Of CAIV-T Against Inactivated Influenza Vaccine In Children 6-59 Months Of Age
  ClinicalTrials.gov Identifier: NCT00128167 - Completed
  Influenza
  
• Biomarkers of Homeopathy in Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00065702 - Completed
  Fibromyalgia
  
• Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
  ClinicalTrials.gov Identifier: NCT00000302 - Completed
  Heroin Dependence
  
• Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 –
  ClinicalTrials.gov Identifier: NCT00192166 - Completed
  Influenza
  
• A Safety and Efficacy Study of Intravenous E5564 in Patients with Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00046072 - Completed
  Sepsis; Shock, Septic; Sepsis Syndrome; Septicemia; Infection
  
• Treatment for Subjects with Active Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00110903 - Completed
  Rheumatoid Arthritis
  
• Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
  ClinicalTrials.gov Identifier: NCT00567385 - Completed
  Growth Hormone Deficiency (GHD)
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older
  ClinicalTrials.gov Identifier: NCT00192153 - Completed
  Influenza
  
• A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00160602 - Completed
  Rheumatoid Arthritis
  
• Open-Label Study to Compare Sevelamer Carbonate Powder Dosed Once Per Day to Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Patients With Chronic Kidney Disease on Hemodialysis.
  ClinicalTrials.gov Identifier: NCT00268957 - Completed
  Chronic Kidney Disease; Hemodialysis; Hyperphosphatemia; Chronic Renal Insufficiency; End Stage Renal Disease
  
• Determinants in Antidepressant Outcomes
  ClinicalTrials.gov Identifier: NCT00108316 - Terminated
  Depression
  
• Garlic in Hyperlipidemia Caused by HAART
  ClinicalTrials.gov Identifier: NCT00029250 - Terminated
  HIV Infections; Hypercholesterolemia; Hypertriglyceridemia; Hyperglycemia